BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Ciprofibrate
,
rs6983267
,
IL1A
,
Metabolism of xenobiotics
,
Allergy to pollen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
miR 142
Summary
General Info
Curated Studies
Most Correlated Studies
T lymphocytes from miR-142 knockout mice
B cells CD19+ from mice with miR-142 knockout
Myeloid-derived suppressor cells from bone marrow cells overexpressing miR 142-3P mimic
Embryonic kidney HEK293 cells treated with miRNA-142-3p, miR-K10a and their 5' isomers
Knockdown of miR-126 in HUVECs
Explore Curated Studies Results
Literature
Most Relevant Literature
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis.
Increased intracellular miR-142 in adults with Type 1 diabetes.
The miR-142 miRNAs: Shaping the naïve immune system.
Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blas…
A gain-of-function mutation in microRNA 142 is sufficient to cause the development of T-cell leukemi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
miR-142-3p as Potential Biomarker of Synaptopathy in MS
The Role of iTBS in Bipolar II Depression
Air Pollution, Asthma and Circadian Clocks
miRNAs in Periodontal Disease
Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ